Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous renal replacement therapies.

Luis Jorge Rodrigues Gaspar1, Nelson Martins Moreira, Aires Ademar Moutinho

  • 1Hospital São João, Nephrology Department, Oporto, Portugal.

EDTNA/ERCA Journal (English Ed.)
|October 10, 2002
PubMed
Summary

Continuous Renal Replacement Therapy (CRRT) offers clinical advantages over conventional hemodialysis for critically ill patients. This therapy provides better hemodynamic tolerance due to slow removal of fluid and toxins, aiding acute renal failure treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Puncture of the arteriovenous fistula: bevel upward or bevel downward?

EDTNA/ERCA journal (English ed.)·2003
See all related articles

Area of Science:

  • Nephrology
  • Intensive Care Medicine

Background:

  • Critically ill patients with multiple organ failure and acute renal failure often experience hypotension, complicating conventional hemodialysis.
  • Continuous Renal Replacement Therapy (CRRT) is a frequently utilized treatment in intensive care units for these patients.

Purpose of the Study:

  • To evaluate the clinical outcomes and survival rates of patients treated with CRRT in an intensive care unit setting.
  • To compare the efficacy and tolerability of CRRT with conventional hemodialysis in a high-risk patient population.

Main Methods:

  • A retrospective analysis of 58 patients undergoing CRRT in the year 2000.
  • Patients received either continuous veno-venous hemofiltration (14 patients) or continuous veno-venous hemodiafiltration (44 patients).
  • Patient demographics, underlying conditions (sepsis, post-surgery, multiple organ failure), and treatment outcomes were recorded.

Related Experiment Videos

Main Results:

  • The mean patient age was 61.7 years, with 36 males and 22 females.
  • Common indications included sepsis (43.1%), post-open-heart surgery (31%), and multiple organ failure (12%).
  • Overall survival was 37.8% (22 patients), with 17.2% recovering renal function and 20.6% requiring ongoing hemodialysis.

Conclusions:

  • CRRT demonstrates clinical advantages, particularly in hemodynamic tolerability, due to its slow fluid and toxin removal.
  • CRRT appears to be a viable alternative to conventional hemodialysis for managing acute renal failure in critically ill patients.
  • Despite high mortality in this severe patient group, CRRT offers a potential treatment option with some patients achieving renal recovery or requiring chronic dialysis.